Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression on track for Q2 2026VLS-01 Phase 2 Elumina topline results ...
Detailed price information for Adamas Trust Inc (ADAM-Q) from The Globe and Mail including charting and trades.
Q1 2026 Management View "We delivered GAAP earnings per share of $0.41 and EAD of $0.29 per share, representing a 26% increase from prior quarter and well in excess of our $0.23 dividend." (CEO & ...